Dual HER/VEGF receptor targeting inhibits in vivo ovarian cancer tumor growth. [electronic resource]
Producer: 20140804Description: 2909-16 p. digitalISSN:- 1538-8514
- Animals
- Antineoplastic Agents -- administration & dosage
- Cell Line, Tumor
- Cluster Analysis
- Disease Models, Animal
- Disease Progression
- Female
- Humans
- Mice
- Neoplasm Grading
- Ovarian Neoplasms -- drug therapy
- Piperidines -- administration & dosage
- Protein Kinase Inhibitors -- administration & dosage
- Proteomics
- Pyrroles -- administration & dosage
- Quinazolines -- administration & dosage
- Receptors, Vascular Endothelial Growth Factor -- antagonists & inhibitors
- Signal Transduction
- Triazines -- administration & dosage
- Tumor Burden -- drug effects
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.